A trading update from mass spectrometry equipment company Microsaic Systems (MSYS) commences that “revenues for FY21 have significantly exceeded those of FY20, recovering to a level slightly ahead of that in FY19, a pre-pandemic benchmark” and includes CEO Glenn Tracey “absolutely delighted”. So what of a current share price response down to around 0.19p?...
The CEO of Microsaic Systems (MSYS) Glenn Tracey is “thrilled to report this transformational performance for the first half of 2021”. The shares have responded to the half-year results announcement to currently 0.22p, more than 12% lower! So what’s going on?...
On 22nd December Microsaic Systems (MSYS) announced that it had appointed KRE Corporate Recovery “to explore other remaining options to maximise value for creditors and potentially other stakeholders”. It was “other remaining options” as a formal sale process had failed – and the shares fell back. However, they have recently significantly recovered and now a further statement from the company has been required...
Shares in Microsaic Systems (MSYS) are down by 60% today. Mr Market is showing Christmas generosity, this stock is still anywhere between 60% and 100% too high...
“Microsaic Systems plc (MSYS), the developer of point of need mass spectrometry instruments, is pleased to announce its unaudited interim results for the six months ended 30 June 2020 and an update on trading since the period end”. Encouraging then?...
Previously writing on Microsaic Systems (MSYS), in March with the shares at 0.80p I concluded it’s not the board’s belief which is important here and note the fundraising is required following the above financials and from a current £3.65 million market cap. Readers here should not be surprised by this latest and, natch, currently the stance remains avoid / sell. Now a “Strategic Review and Formal Sale Process” announcement – and the shares 0.35p...
